Plasma Thrombopoietin Level in Thrombocytopenic Patients with or without Liver Cirrhosis Chronically Infected by the Hepatitis C Virus
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2015, Vol 5, Issue 7
Abstract
Background and Aim: Thrombocytopenia is a frequent problem in patients with post- hepatitis C (HCV) liver cirrhosis and also occurs in chronic HCV-infected patients without liver cirrhosis. The aim of this study was to evaluate the role of plasma thrombopoietin (TPO) in the occurrence of thrombocytopenia in both conditions. Method: Platelet count and plasma thrombopoietin level and liver function tests were measured in four groups of patients: twenty chronic patients with post-hepatitis C liver cirrhosis and thrombocytopenia (group I), ten chronic HCV-positive patients with liver cirrhosis without thrombocytopenia (group II), ten chronic HCV-positive patients without liver cirrhosis with thrombocytopenia (group III) and chronic ten HCV-positive patients without liver cirrhosis and without thrombocytopenia (group IV). Ten normal healthy individuals were included as a control group. Results: Plasma levels of albumin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), TPO and platelet counts in the four groups of patients were significantly different from their corresponding levels in the control group (P <0.001). There was a significant positive correlation between plasma TPO levels and platelet counts in group III patients (ρ (Spearman's [rho]) = 0.661, P= 0 .038). There was no significant correlation between TPO levels and platelet counts in the other three groups of patients. The logistic regression analysis in the three designated models, using dependent variables (chronic HCV infection, liver cirrhosis and thrombocytopenia) and an independent variable (TPO plasma level) revealed that liver cirrhotic patient and the thrombocytopenic patient have equally the best prediction model for the low plasma TPO. Conclusion: Decreased thrombopoietin production has a role in the pathogenesis of thrombocytopenia in liver cirrhosis.
Authors and Affiliations
Aiman Al-Qtaitat, Said Al-Dalaen, Samir Mahgoub, Nedal Alnawaiseh, Jehad Al-Shuneiqat, Sameeh Al-Sarayreh, Yousef Al –Saraireh
Keywords
Related Articles
- EP ID EP345019
- DOI 10.9734/BJMMR/2015/9860
- Views 58
- Downloads 0
Prescribing Patterns of Antibiotics for Community-Acquired Pneumonia in Adult in King Saud Hospital
Background: Community acquired pneumonia (CAP) is defined as a presence of symptoms and signs consistent with an acute lower respiratory tract infection associated with new radiographic shadowing for which there is no ot...
Quality of Life in Patients with Chronic Kidney Disease: A Cross-sectional Study Comparing Patients on Hemodialysis, Peritoneal Dialysis and with Kidney Transplantation
Aims: The methods of renal replacement therapy influence highly the quality of life (QOL) of patients with chronic kidney disease. The present study aimed to evaluate and compare the QOL in patients undergoing hemodialys...
Hepatic Antioxidant Effect of Paroxetine in Rats Exposed to Chronic Restraint Model
Depressed mood, with its accompanying mental and physical stresses, could affect the progression and severity of several diseases e.g. hypertension, myocardial infarction, gastritis, peptic ulcer. The present animal stud...
Two Sisters with Gaucher Disease: Focus on the Effectiveness of Imiglucerase Treatment: Case Reports
Gaucher disease is an autosomal recessive lysosomal storage disease caused by beta glucocerebrosidase enzyme deficiency leading glucosylceramide deposition in reticuloendothelial system (RES) cells. Gaucher cell loaded b...
The Prevalence of the Carabelli Trait in Selected Nepalese Population
Aims: The purpose of this study is to determine the prevalence and degree of expression of the carabelli trait in the permanent first and second maxillary molars in a selected Nepalese population residing in Madi village...